For Research Use Only. Not for use in diagnostic procedures.
The AVENIO ctDNA Targeted Kit V2 is a next-generation sequencing (NGS) liquid biopsy research assay that contains 17 genes, including those in U.S. National Comprehensive Cancer Network (NCCN) Guidelines.1 The Targeted panel may be used for pan-cancer research applications, but is specially optimized for lung cancer and colorectal cancer (CRC) research. The AVENIO ctDNA Targeted Kit V2 is an efficient tumor profiling solution.
The AVENIO ctDNA Targeted Kit V2 is a part of the AVENIO family of NGS oncology research assays that include three ctDNA and three corresponding tumor tissue assays. By using the wider family of AVENIO assays, labs can obtain detailed molecular findings across all four mutation classes from plasma or tissue samples.